I think there is considerable potential for this drug (and class) as a treatment for obstructive sleep apnea
Discover how GLP-1 receptor activation reduces appetite, slows gastric emptying, enhances insulin secretion, and decreases glucagon release, while GIP receptor agonism further supports insulin regulation, improves tolerability, and enhances fat metabolism
Peptides are investigational compounds with specific dosing protocols, contraindications, and potential interactions
Monoagonistas del receptor de GLP-1 para el tratamiento de la obesidad: liraglutida y semaglutida La primera molcula que se comercializ para el tratamiento de la obesidad fue liraglutida (LIRA), de administracin subcutnea diaria, que alcanz el mercado en 2014
Its high in empty calories, and certain drinks, like cocktails or sweet wines, can spike your blood sugar or leave you feeling bloated